Description
GDC-6036 is a KRAS G12C covalent inhibitor.
Product Unit Size | Cost | Quantity | Stock |
---|
GDC-6036 is a KRAS G12C covalent inhibitor.
Cas No. | 2417987-45-0 |
---|---|
Purity | ≥98% |
Formula | C29H32ClF4N7O2 |
Formula Wt. | 622.07 |
IUPAC Name | 1-[(3S)-4-[7-[6-amino-4-methyl-3-(trifluoromethyl)pyridin-2-yl]-6-chloro-8-fluoro-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]quinazolin-4-yl]-3-methylpiperazin-1-yl]prop-2-en-1-one |
Synonym | GDC6036 |
Appearance | White powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Cascetta P, Marinello A, Lazzari C, et al. KRAS in NSCLC: state of the art and future perspectives. Cancers (Basel). 2022 Nov 4;14(21):5430. PMID: 36358848
Endogenous peptide hormone, involved in feeding...
Statin; HMG-CoA reductase inhibitor.
ITC, used as chiral agent.
Endogenous peptide hormone, GLP-1 fragment, inv...
Dibenzocyclooctadiene found in Schisandra.
Trichothecene mycotoxin produced by Fusarium; p...
β2-adrenergic agonist, potential ENaC activato...
Triterpenoid
β-lactamase inhibitor.
Endogenous peptide hormone, somatostatin analog...
BRD2/3/4 inhibitor.
Cysteine-ITC conjugate, antioxidant.
Triazolopyrazine; c-MET inhibitor.
Mycotoxin; F1F0 ATP synthase inhibitor.
Peptide fragment of VSV; LDLR agonist.
Benzofuroxan derivative; MDMX inhibitor.
Potential voltage-gated Na+ channel blocker.
Impurity of omeprazole
V600E B-Raf inhibitor.
Peptide, oxytocin analog; potential OXTR agonis...